Product Information
PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0895 per EA under NDC 57237022030. Its NADAC has been published 451 times since Nov 8, 2017.
Strength
30 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237022030
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200268On Market Since
2/13/2013
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 451 times since Nov 8, 2017, and over the history we have for it it has declined 40.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0895 per EA |
|---|---|
| All-time high | $0.1632 (Oct 14, 2020) |
| All-time low | $0.0828 (Nov 20, 2024) |
| 52-week high | $0.1019 |
| 52-week low | $0.0895 |
| Median price | $0.1166 |
| Average price | $0.1214 |
| Largest weekly change | +24.7% (Jun 19, 2024) |
| Weeks tracked | 451 |
| Tracking since | Nov 8, 2017 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0895 per EA (NDC 57237022030), effective Jun 24, 2026.
How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 40.3%. It has been tracked across 451 weekly CMS publications since Nov 8, 2017.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?
Since Nov 8, 2017, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.1632 (Oct 14, 2020), with a median of $0.1166 per EA.
Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as PIOGLITAZONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures PIOGLITAZONE HCL 30 MG TABLET?
PIOGLITAZONE HCL 30 MG TABLET (NDC 57237022030) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification